Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hanan Abdel Moneam A. Shamardl"'
Autor:
Hanan Abdel Moneam A. Shamardl, Noha A. Ibrahim, Dina H. Merzeban, Azza M. Elamir, Rehab M. Golam, Asmaa M. Elsayed
Publikováno v:
DARU Journal of Pharmaceutical Sciences.
Background Adiposity and non-alcoholic fatty liver disease (NAFLD) are common characteristics of metabolic syndrome (MS). Understanding the underlying pathogenesis is crucial for the development of new remedies. Resveratrol controls obesity and glyce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::996aed5e419032ffaef3cb2c21584830
https://doi.org/10.1007/s40199-023-00458-y
https://doi.org/10.1007/s40199-023-00458-y
Publikováno v:
The American Journal of the Medical Sciences. 354:190-198
Background Hypertension is one of the primary modifiable risk factors for cardiovascular disease. Adequate vitamin D (vit D) levels have been shown to reduce vascular smooth muscle contraction and to increase arterial compliance, which may be benefic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b93d6663a7026bf1756e82867d3df712
https://doi.org/10.1016/j.amjms.2017.04.007
https://doi.org/10.1016/j.amjms.2017.04.007
Autor:
Ebtessam A. Essa, Hanan Abdel Moneam A. Shamardl, Gehan F. Balata, Samira H Zaidan, Mohammed A.S. Abourehab
Publikováno v:
Drug Design, Development and Therapy
Gehan F Balata,1 Ebtessam A Essa,1,2 Hanan A Shamardl,3,5 Samira H Zaidan,4 Mohammed AS Abourehab1,6 1Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia; 2Department of Pharmaceutics, Faculty of Pharmacy, T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37dfe0406e0d05b9df49b24ca34ecc9e
http://europepmc.org/articles/PMC4708959
http://europepmc.org/articles/PMC4708959